Dechra unveils Recicort® - a solution for ear inflammation in pets

Dechra unveils Recicort® - a solution for ear inflammation in pets

maandag 15 juli 2019

Dechra Veterinary Products has revealed a treatment to provide relief from irritating ear conditions for cats and dogs.

It has rolled out Recicort® ear drops for otitis externa with inflammation and seborrheic dermatitis of the ear pinna to the UK market.

Recicort’s combination of ingredients - triamcinolone acetonide and salicylic acid – work together to provide effective symptomatic treatment and is particularly useful for targeting certain types of otitis externa that are not caused by a bacterial or yeast infection such as flare ups caused by allergies.

Dechra Brand Manager Carol Morgan said: “Otitis externa is a condition that causes inflammation of the external ear canal and it can have a debilitating effect on cats and dogs.

“Recicort is a moderately potent steroid with an anti-inflammatory and vasoconstrictive action that works by suppressing the inflammatory response and the symptoms of various disorders often associated with itching. It doesn’t contain an antibiotic or antimycotic so it won’t contribute to antimicrobial resistance either. 

“This prescription only treatment is an important addition to our dermatology portfolio for veterinary professionals who are looking for a suite of highly effective and cost effective treatments.”

Recicort joins other products in the Dechra dermatology range including market leaders Canaural® ear drops and CleanAural®, an ear cleaner for cats and dogs.

Recicort is available in an easy to administer practical 20 ml bottle. For more information click here.